why choose us

First received: January 02, 2023

Clinical Trial: PMS of Spesolimab I.V. in GPP Patients With Acute Symptoms

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Generalized Pustular Psoriasis

Study Type: OBSERVATIONAL


Official Title: Post-marketing Surveillance of Spesolimab I.V. Infusion in Improvement of Generalized Pustular Psoriasis (GPP) With Acute Symptoms in Japan

Brief Summary: Non-interventional cohort study in patients with newly initiated Spesolimab to evaluate the incidence of adverse drug reactions and to understand generalized pustular psoriasis (GPP) disease activities in the real world setting.

Read more